clopidogrel has been researched along with valerates in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cui, W; Du, D; Hu, X; Shi, H; Sun, L; Tian, J; Yu, T; Zhang, X | 1 |
Chen, L; He, W; Jing, F; Long, T; Qin, G; Zhang, D; Zhang, Y; Zhou, J | 1 |
2 other study(ies) available for clopidogrel and valerates
Article | Year |
---|---|
P2Y12 regulates microglia activation and excitatory synaptic transmission in spinal lamina II neurons during neuropathic pain in rodents.
Topics: Adenine; Animals; Clopidogrel; Disease Models, Animal; Excitatory Postsynaptic Potentials; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Neuralgia; Neurons; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; rho GTP-Binding Proteins; Signal Transduction; Spinal Cord; Spinal Cord Dorsal Horn; Spinal Cord Injuries; Spinal Nerves; Synaptic Transmission; Valerates | 2019 |
P2Y12 receptor mediates microglial activation via RhoA/ROCK pathway in the trigeminal nucleus caudalis in a mouse model of chronic migraine.
Topics: Adenine; Animals; Clopidogrel; Disease Models, Animal; Mice; Microglia; Migraine Disorders; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Trigeminal Nuclei; Valerates | 2019 |